Elagolix/estradiol/norethindrone acetate

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameElagolix/estradiol/norethindrone acetate
Drug Alias NameOriahnn
ClassificationSmall molecules
Mechanisms of ActionProgesterone receptor agonistsEstrogen receptors agonistsSignal-regulatory protein alpha inhibitors
TargetsEstrogen receptorsSignal-regulatory protein alphaProgesterone receptor
Therapy Area/IndicationsMenorrhagia
Global Approved IndicationsMenorrhagia
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2020/05/29
Country/TerritoryUnited States
CombinationsYes
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesAbbvie Inc
China Registration ClassN/A

Develop Information

Active CompaniesAbbvie Inc
Inactive CompaniesN/A
Active IndicationsMenorrhagia
Inactive IndicationsN/A

Other Information

ATC CodeG03CA53
Related LinksN/A